Recommend to a friend
Immune Checkpoint Inhibitors and RCC: Where Are We Now?
This case based panel discussion reviews the recent guidelines and the latest clinical information related to the treatment of RCC with immunotherapeutic agents.
Friend's Name :
Friend's email :
You may provide a message here that will be included in the emailed recommendation. (2000 Character Max)
Characters written:
Your comment
Send recommendation
